News Release - Siegfried

ePAPER READ

DOWNLOAD ePAPER

siegfried.ch

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

Seite 2

About Avesta Biotherapeutics and Research Pvt. Ltd. (ABRPL)

Avesta Biotherapeutics and Research Pvt. Ltd. (ABRPL) is a joint venture (JV) between

Avestha Gengraine Technologies Pvt Ltd. (Avesthagen) and Meditab Specialities Ltd.

(of CIPLA group). The JV, ABRPL, based in Bangalore, will manufacture a series of

biopharmaceuticals primarily for the Indian market. In addition, the venture will exploit

opportunities in biological Contract Manufacturing worldwide.“

Reden von G. Achermann, VR-PrÃ¤sident & R. Hanko, CEO - Siegfried

Micro-Reactor Technology (MRT) A continuous reactor system for ...

Siegfried â wenn die Substanz zÃ¤hlt GeschÃ¤ftsbericht 2008

Medienmitteilung Neuer Verwaltungsrat fÃ¼r Siegfried

Medienmitteilung_GL_Mai_11_FV D - Siegfried

Seite 2 About Avesta Biotherapeutics and Research Pvt. Ltd. (ABRPL) Avesta Biotherapeutics and Research Pvt. Ltd. (ABRPL) is a joint venture (JV) between Avestha Gengraine Technologies Pvt Ltd. (Avesthagen) and Meditab Specialities Ltd. (of CIPLA group). The JV, ABRPL, based in Bangalore, will manufacture a series of biopharmaceuticals primarily for the Indian market. In addition, the venture will exploit opportunities in biological Contract Manufacturing worldwide.“

Page 1: News Release The Siegfried Group se

News Release - Siegfried

Create successful ePaper yourself

Delete template?

Save as template?